Toru Satoh

13.7k total citations · 5 hit papers
201 papers, 9.2k citations indexed

About

Toru Satoh is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Toru Satoh has authored 201 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pulmonary and Respiratory Medicine, 107 papers in Cardiology and Cardiovascular Medicine and 27 papers in Genetics. Recurrent topics in Toru Satoh's work include Pulmonary Hypertension Research and Treatments (114 papers), Cardiovascular Function and Risk Factors (48 papers) and Cardiovascular Issues in Pregnancy (28 papers). Toru Satoh is often cited by papers focused on Pulmonary Hypertension Research and Treatments (114 papers), Cardiovascular Function and Risk Factors (48 papers) and Cardiovascular Issues in Pregnancy (28 papers). Toru Satoh collaborates with scholars based in Japan, United States and United Kingdom. Toru Satoh's co-authors include Norifumi Nakanishi, Shingo Kyotani, Noritoshi Nagaya, Fumio Sakamaki, Kunio Miyatake, Masaaki Uematsu, Yoshiaki Okano, Keiichi Fukuda, Marius M. Hoeper and Masaharu Kataoka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Toru Satoh

200 papers receiving 9.0k citations

Hit Papers

Definitions and Diagnosis of Pulmonary Hype... 2000 2026 2008 2017 2013 2000 2000 2013 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Definitions and Diagnosis of Pulmonary Hypertension
    2013 1.3k citations Marius M. Hoeper, Toru Satoh et al. Journal of the American College of Cardiology profile →
  2. Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise Testing
    2000 857 citations Shoichi Miyamoto, Noritoshi Nagaya et al. American Journal of Respiratory and Critical Care Medicine profile →
  3. Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
    2000 660 citations Noritoshi Nagaya, Masaaki Uematsu et al. Circulation profile →
  4. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
    2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →
  5. Diagnosis of pulmonary hypertension
    2018 297 citations Adaani Frost, Toru Satoh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toru Satoh Japan 42 6.5k 5.1k 1.2k 1.1k 1.1k 201 9.2k
Laurent Savale France 52 6.6k 1.0× 3.4k 0.7× 1.5k 1.2× 1.3k 1.2× 798 0.7× 251 8.3k
Stephan Rosenkranz Germany 54 5.2k 0.8× 5.6k 1.1× 692 0.6× 1.3k 1.2× 1.9k 1.8× 267 10.0k
Harm Jan Bogaard Netherlands 54 9.5k 1.5× 7.0k 1.4× 699 0.6× 1.8k 1.7× 1.8k 1.7× 310 12.5k
Philippe Hervé France 48 6.6k 1.0× 3.9k 0.8× 1.3k 1.0× 2.0k 1.9× 652 0.6× 131 8.9k
Michael A. Mathier United States 36 3.9k 0.6× 4.2k 0.8× 504 0.4× 1.6k 1.5× 666 0.6× 124 6.8k
David P. Jenkins United Kingdom 40 3.7k 0.6× 3.2k 0.6× 1.1k 0.9× 945 0.9× 522 0.5× 163 6.4k
Bertron Μ. Groves United States 37 5.2k 0.8× 4.0k 0.8× 798 0.6× 1.1k 1.1× 807 0.8× 96 8.3k
Roberto F. Machado United States 46 4.4k 0.7× 2.2k 0.4× 3.6k 2.9× 795 0.7× 1.5k 1.4× 191 9.6k
Yoshihiro Fukumoto Japan 49 2.4k 0.4× 3.6k 0.7× 482 0.4× 1.7k 1.6× 2.1k 1.9× 309 8.6k
Aaron B. Waxman United States 41 4.0k 0.6× 2.4k 0.5× 323 0.3× 723 0.7× 978 0.9× 173 6.0k

Countries citing papers authored by Toru Satoh

Since Specialization
Citations

This map shows the geographic impact of Toru Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Satoh more than expected).

Fields of papers citing papers by Toru Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Satoh. The network helps show where Toru Satoh may publish in the future.

Co-authorship network of co-authors of Toru Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Satoh. A scholar is included among the top collaborators of Toru Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Satoh. Toru Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Melissa L., Mark M. Awad, Martin Gutierrez, et al.. (2023). OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study. Journal of Thoracic Oncology. 18(11). S54–S55. 23 indexed citations
2.
Sawada, Yoichi, et al.. (2023). Validity and reliability of a computerized cognitive function evaluation battery (CogEvo) as a screening tool. SHILAP Revista de lepidopterología. 2(1). e67–e67. 3 indexed citations
3.
Isobe, Sarasa, et al.. (2016). Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade. American Journal of Respiratory and Critical Care Medicine. 193(11). 1310–1314. 8 indexed citations
4.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →
5.
Kataoka, Masaharu, Takumi Inami, Kenichi Matsushita, et al.. (2013). Single Nucleotide Polymorphisms of the ALK1 and ENG Genes in Patients with Pulmonary Arterial Hypertension. 44(3). 137–142. 1 indexed citations
6.
Murata, Masatsune, Toru Satoh, Hiroyuki Wakabayashi, et al.. (2013). Oral administration of bovine lactoferrin attenuates ultraviolet B-induced skin photodamage in hairless mice. Journal of Dairy Science. 97(2). 651–658. 15 indexed citations
7.
Ishiguro, Haruhisa, Masaharu Kataoka, Takumi Inami, et al.. (2013). Percutaneous Transluminal Pulmonary Angioplasty for Central-Type Chronic Thromboembolic Pulmonary Hypertension. JACC: Cardiovascular Interventions. 6(11). 1212–1213. 20 indexed citations
8.
Inami, Takumi, Masaharu Kataoka, Nobuhiko Shimura, et al.. (2012). Left Ventricular Dysfunction Due to Diffuse Multiple Vessel Coronary Artery Spasm can be Concealed in Dilated Cardiomyopathy. European Journal of Heart Failure. 14(10). 1130–1138. 17 indexed citations
9.
Moriyama, Kiyoshi, et al.. (2012). Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy. Journal of Clinical Anesthesia. 24(6). 487–489. 3 indexed citations
10.
Murata, Mitsushige, Shigeo Okuda, Hikaru Tsuruta, et al.. (2011). Quantitative Analysis of Right Ventricular Function in Patients With Pulmonary Hypertension Using Three-Dimensional Echocardiography and a Two-Dimensional Summation Method Compared to Magnetic Resonance Imaging. The American Journal of Cardiology. 107(3). 484–489. 37 indexed citations
11.
Kataoka, Masaharu, Noritoshi Nagaya, Toru Satoh, et al.. (2005). A Long-Acting Prostacyclin Agonist with Thromboxane Inhibitory Activity for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(12). 1575–1580. 40 indexed citations
12.
Satoh, Toru, et al.. (2005). Methicillin Resistant Staphylococcus Aureus Infection of Implantable Antiarrhythmic Device. Circulation. 69. 617. 16 indexed citations
13.
Yoshizawa, Akihiro, Tsutomu Yoshikawa, Iwao Nakamura, et al.. (2004). Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure. Journal of Cardiac Failure. 10(4). 310–315. 21 indexed citations
14.
Satoh, Toru, Shingo Kyotani, Yoshiaki Okano, Norifumi Nakanishi, & Takeyoshi Kunieda. (2004). Descriptive patterns of severe chronic pulmonary hypertension by chest radiography. Respiratory Medicine. 99(3). 329–336. 16 indexed citations
15.
Meng, Fanbo, Tsutomu Yoshikawa, Akiyasu Baba, et al.. (2003). β-Blockers are effective in congestive heart failure patients with atrial fibrillation. Journal of Cardiac Failure. 9(5). 398–403. 18 indexed citations
16.
Yoshikawa, Tsutomu, Akihiro Yoshizawa, Iwao Nakamura, et al.. (2003). Brain Natriuretic Peptide Level Is a Predictor of Efficacy, but not a Sensitive Marker during β-Blocker Therapy for Heart Failure. Japanese Circulation Journal-english Edition. 67. 40. 1 indexed citations
17.
Anzai, Toshihisa, Tsutomu Yoshikawa, Toshiyuki Takahashi, et al.. (2003). Early Use of Beta-Blockers Is Associated with Attenuation of Serum C-Reactive Protein Elevation and Favorable Short-Term Prognosis after Acute Myocardial Infarction. Cardiology. 99(1). 47–53. 48 indexed citations
18.
Miyamoto, Shoichi, Noritoshi Nagaya, Toru Satoh, et al.. (2000). Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise Testing. American Journal of Respiratory and Critical Care Medicine. 161(2). 487–492. 857 indexed citations breakdown →
19.
Nagaya, Noritoshi, Masaaki Uematsu, Toru Satoh, et al.. (1999). Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 160(2). 487–492. 211 indexed citations
20.
Nakayama, Yasunori, Norifumi Nakanishi, Masaru Sugimachi, et al.. (1997). Characteristics of Pulmonary Artery Pressure Waveform for Differential Diagnosis of Chronic Pulmonary Thromboembolism and Primary Pulmonary Hypertension. Journal of the American College of Cardiology. 29(6). 1311–1316. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Savale Breakdown of academic impact, for papers by Stephan Rosenkranz Breakdown of academic impact, for papers by Harm Jan Bogaard Breakdown of academic impact, for papers by Philippe Hervé Breakdown of academic impact, for papers by Michael A. Mathier Breakdown of academic impact, for papers by David P. Jenkins Breakdown of academic impact, for papers by Bertron Μ. Groves Breakdown of academic impact, for papers by Roberto F. Machado Breakdown of academic impact, for papers by Yoshihiro Fukumoto Breakdown of academic impact, for papers by Aaron B. Waxman
Rankless by CCL
2026